http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-0001385-A2

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 1997-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f47246a0feb4cfaa066723a31c6133d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57ad9b0be692283069f9bb71336ec9dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70d35a28682d28bd11b324e08d0f29e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3fd06da239a510c52a0f292a705c007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64775e9b9494c56eb692f3fb26d9d2c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39ecf135400b25f810008a02b0078cde
publicationDate 2000-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-0001385-A2
titleOfInvention Precursors and derivatives of camptothecin, a process for their preparation, their use and pharmaceutical compositions containing them
abstract InterLn = 1333;> (57) The present invention relates to novel camptothecin derivatives wherein the hydroxylactone group of camptothecin is replaced by a b-hydroxy lactone group or a corresponding b-hydroxy acid resulting from the opening of a lactone. The novel compounds are characterized in that they contain an optionally substituted oxazine ring which fits at positions 10 and 11 of the A ring. The present invention also relates to the preparation of novel compounds and pharmaceutical compositions prepared therefrom. The compounds of the present invention have antitumor, antiviral and parasiticidal properties. SHE
priorityDate 1996-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12313776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481343
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421208039

Total number of triples: 30.